X hits on this document

Word document

The usefulness and use of second-generation - page 53 / 81





53 / 81

166 Claus A, Bollen J, De Cuyper H, et al. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study. Acta Psychiatr Scand 1992; 85:295-305.

167 Lewis R, Bagnall A, Leitner M. Sertindole for schizophrenia. Cochrane Database Syst Rev 2000; CD001715.

168 Lesem MD, Zajecka JM, Swift RH, et al. Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 2001; 62:12-18.

169. Brook S, Lucey JV, Gunn KP. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group. J Clin Psychiatry 2000; 61:933-941.

170 Bagnall A, Lewis RA, Leitner ML. Ziprasidone for schizophrenia and severe mental illness. Cochrane Database Syst Rev 2000; CD001945.

171 Cooper SJ, Butler A, Tweed J, et al. Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia. Psychopharmacology (Berl) 2000; 150:237-243.

172 Cooper SJ, Tweed J, Raniwalla J, et al. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Acta Psychiatr Scand 2000; 101:218-225.

173 Petit M, Raniwalla J, Tweed J, et al. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial. Psychopharmacol Bull 1996; 32:81-87.

174 Barnas C, Stuppack CH, Miller C, et al.  Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol. Int Clin Psychopharmacol 1992; 7:23-27.

175 Harada T, Otsuki S, Fujiwara Y. Effectiveness of zotepine in therapy-refractory psychoses. An open, multicenter study in eight psychiatric clinics. Fortschr Neurol Psychiatr 1991; 59 (Suppl 1):41-44.

176 Klieser E, Lehmann E, Tegeler J. Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients. Fortschr Neurol Psychiatr 1991; 59 (Suppl 1):14-17.

177 Muller-Spahn F, Dieterle D, Ackenheil M. Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial. Fortschr Neurol Psychiatr 1991; 59 (Suppl 1):30-35.

Document info
Document views331
Page views331
Page last viewedTue Jan 24 05:35:56 UTC 2017